Clinical Trials
A Phase 1, open-label trial of belzupacap sarotalocan (AU-011) to determine the feasibility and safety of intratumoral injection with or without intramural injection in subjects with bladder cancer (CTMS#22-0121)
ClinicalTrials.gov Identifier
ClinicalTrials.gov registration not required
Principal Investigator
Ahmed Mansour Elkenany MD